Procter & Gamble (PG) EBIT (2009 - 2026)

Procter & Gamble (PG) has 18 years of EBIT data on file, last reported at $4.6 billion in Q1 2026.

• EBIT for Q1 2026 came in at $4.6 billion, changed 0.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.2 billion (up 0.86% YoY), and the FY2025 annual result was $20.5 billion, up 10.28% from the prior year.
• EBIT retreated to $4.6 billion in Q1 2026 per PG's latest filing, from $5.4 billion in the prior quarter.
• Over five years, EBIT peaked at $5.9 billion in Q3 2025 and troughed at $3.6 billion in Q2 2022.
• A 5-year average of $4.7 billion and a median of $4.6 billion in 2025 frame the typical range for EBIT.
• The sharpest annual moves came in 2022 and 2024: EBIT retreated 7.41% in 2022, then gained 29.51% in 2024.
• A 5-year view of EBIT shows it stood at $4.8 billion in 2022, then slipped by 7.36% to $4.4 billion in 2023, then advanced by 29.51% to $5.7 billion in 2024, then slipped by 6.53% to $5.4 billion in 2025, then declined by 14.72% to $4.6 billion in 2026.
• Business Quant data shows PG's EBIT at $4.6 billion in Q1 2026, $5.4 billion in Q4 2025, and $5.9 billion in Q3 2025.